• Most countries in Latin America are price-sensitive; the comodato market model is well established here. During the pandemic, the supply of dedicated infusion sets was affected, with many manufacturing sites impacted by the various national lockdowns. Many countries were also able to utilise capital revenues to purchase new equipment as part of large governmental stimulus packages. As such, the number of pumps that were sold in 2020 increased, compared to that in 2019. This proportion reverted to normal levels in 2021 and comodato will continue to be the preferred purchasing method through to 2026.

EMEA:
• Demand for infusion solutions in the ICU in Western Europe increased in 2020, resulting in several emergency purchase tenders. Most notable demand was seen in Italy, France, Spain and the U.K. The pandemic has resulted in a review of ICU facilities to improve the ratio of equipment to ICU beds. However, many fiscal packages have also come to an end, reducing budgets for healthcare. This will result in more cautious purchasing in the near-term, and a slowing down of revenue growth from 2024. The pandemic also highlighted the significant staff shortages; moving forward, demand for solutions that can improve workflow and efficiency will increase.
• Similarly, to Latin America, comodato purchasing is present in Southern Europe and the U.K., and is continuing to spread to other countries. With budgets becoming increasingly restricted, product bundling is expanding to include software solutions in wider service plans, and is expected to become more prominent in the Western Europe.

• Despite being a sizeable market, developments to improve digital healthcare in Russia have been hampered by economic instability, with other solutions often prioritized first. The recent war in Ukraine has also resulted in a diversion of funding, halting developments to improve healthcare provisions in the short-term.

Asia Pacific:
• The Japanese market accounts for the largest proportion of infusion pump revenues to the Mature Asia Pacific region. There is greater preference for large-volume infusion pumps in Japan. The Government’s Health Care 2035 reform is expected to shift the country toward integrated care solutions, further sustaining demand for digitalised solutions that offer preventative care.

• As part of Healthy China 2030, there is a gradual shift toward the provision of smart healthcare systems, with the promotion of smart hospitals. Improvements to IT systems are to be made to enhance the capacity to forecast and provide early warning, analysis and reporting tools. This is further driving demand for digital infusion pumps here.

Business Affairs Homepage